TREM2- and DAP12-Dependent Activation of PI3K Requires DAP10 and Is Inhibited by SHIP1
Open accessThe DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Abstract
The activation and fusion of macrophages and of osteoclasts require the adaptor molecule DNAX-activating protein of 12 kD (DAP12), which contains immunoreceptor tyrosine-based activation motifs (ITAMs). TREM2 (triggering receptor expressed on myeloid cells-2) is the main DAP12-associated receptor in osteoclasts and, similar to DAP12 deficiency, loss of TREM2 in humans leads to Nasu-Hakola disease, which is characterized by bone cysts and dementia. Furthermore, in vitro experiments have shown that deficiency in DAP12 or TREM2 leads to impaired osteoclast development and the formation of mononuclear osteoclasts. Here, we demonstrate that the ligation of TREM2 activated phosphatidylinositol 3-kinase (PI3K), extracellular signal-regulated kinase 1 (ERK1) and ERK2, and the guanine nucleotide exchange factor Vav3; induced the mobilization of intracellular calcium (Ca(2+)) and the reorganization of actin; and prevented apoptosis. The signaling adaptor molecule DAP10 played a key role in the TREM2- and DAP12-dependent recruitment of PI3K to the signaling complex. Src homology 2 (SH2) domain-containing inositol phosphatase-1 (SHIP1) inhibited TREM2- and DAP12-induced signaling by binding to DAP12 in an SH2 domain-dependent manner and preventing the recruitment of PI3K to DAP12. These results demonstrate a previously uncharacterized interaction of SHIP1 with DAP12 that functionally limits TREM2- and DAP12-dependent signaling and identify a mechanism through which SHIP1 regulates key ITAM-containing receptors by directly blocking the binding and activation of PI3K.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In particular, SHIP1 inhibits phagocytic signal transduction by triggering receptor expressed on myeloid cells 2 (TREM2) and tyrosine kinase binding protein (TYROBP, also known as DAP12).11”
From Microglial INPP5D limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer's disease (2023) · cites this paper as [11]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“INPP5D inhibits triggering receptor expressed on myeloid cell 2 (TREM2) signaling by sterically blocking the site where tyrosine-protein kinase (SYK) binds to tyrosine kinase-binding protein (TYROBP), the TREM2 adaptor protein, 10”
From INPP5D deficiency attenuates amyloid pathology in a mouse model of Alzheimer's disease (2023) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“INPP5D negatively regulates signaling via several microglial cell surface receptors, including triggering receptor expressed on myeloid cells 2 (TREM2)”
From INPP5D deficiency attenuates amyloid pathology in a mouse model of Alzheimer's disease (2023) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Multiple studies support the hypothesis that SHIP1 negatively regulates microglia and macrophage phagocytosis, likely through its proposed regulation of TREM2 and TLR4, as well as Fc gamma receptor (FCγR) and complement receptor 3 (CR3)-mediated signaling, and potentially of other signaling pathways [106, 114, 121, 134–138].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [114]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TREM2 is an activating receptor of the Ig-superfamily that binds lipids and transmits intracellular signals through the adaptor DAP12 (Peng et al., 2010; Ulland et al., 2017).”
From TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy (2020) · cites this paper as Peng et al., 2010
Experimental — accuracy not yet measured
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis
Koga, T., Inui, M., Inoue, K., Kim, S., Suematsu, A., Kobayashi, E., Iwata, T., Ohnishi, H., Matozaki, T., Kodama, T., et al. (2004) · Nature · doi:10.1038/nature02444 · Cited by 828
Cutting Edge: TREM-2 Attenuates Macrophage Activation
Turnbull, I. R., Gilfillan, S., Cella, M., Aoshi, T., Miller, M., Piccio, L., Hernandez, M., & Colonna, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.3520 · Cited by 688
Mócsai, A., Humphrey, M. B., Van Ziffle, J. A. G., Hu, Y., Burghardt, A., Spusta, S. C., Majumdar, S., Lanier, L. L., Lowell, C. A., & Nakamura, M. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401602101 · Cited by 463
Self-citationHamerman, J. A., Jarjoura, J. R., Humphrey, M. B., Nakamura, M. C., Seaman, W. E., & Lanier, L. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2051 · Cited by 440
Self-citationNKG2D-DAP10 triggers human NK cell–mediated killing via a Syk-independent regulatory pathway
Billadeau, D. D., Upshaw, J. L., Schoon, R. A., Dick, C. J., & Leibson, P. J. (2003) · Nature Immunology · doi:10.1038/ni929 · Cited by 374
Identification of FcαRI as an Inhibitory Receptor that Controls Inflammation
Pasquier, B., Launay, P., Kanamaru, Y., Moura, I. C., Pfirsch, S., Ruffié, C., Hénin, D., Benhamou, M., Pretolani, M., Blank, U., et al. (2005) · Immunity · doi:10.1016/j.immuni.2004.11.017 · Cited by 346
Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice
Kaifu, T., Nakahara, J., Inui, M., Mishima, K., Momiyama, T., Kaji, M., Sugahara, A., Koito, H., Ujike-Asai, A., Nakamura, A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16923 · Cited by 343
DAP10‐ and DAP12‐associated receptors in innate immunity
Lanier, L. L. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00720.x · Cited by 323
Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12
Hamerman, J. A., Tchao, N. K., Lowell, C. A., & Lanier, L. L. (2005) · Nature Immunology · doi:10.1038/ni1204 · Cited by 318
DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features
Paloneva, J., Mandelin, J., Kiialainen, A., Böhling, T., Prudlo, J., Hakola, P., Haltia, M., Konttinen, Y. T., & Peltonen, L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030027 · Cited by 318
Research works printed but not linked: 1
- 10.4049/jimmunol.177.6.3520 · DOI · Paper page
Cited by
Items 101–200 of 447
The TREM2-DAP12 signaling pathway in Nasu–Hakola disease: a molecular genetics perspective
Humphrey, M. B., Xing, J., & Titus, A. (2015) · Research and Reports in Biochemistry · doi:10.2147/rrbc.s58057 · Cited by 77
Self-citationCui, Y., Chen, C., Tang, Z., Yuan, W., Yue, K., Cui, P., Qiu, X., Zhang, H., Li, T., Zhu, X., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06756-w · Cited by 80
Gawish, R., Martins, R., Böhm, B., Wimberger, T., Sharif, O., Lakovits, K., Schmidt, M., & Knapp, S. (2015) · The FASEB Journal · doi:10.1096/fj.14-260067 · Cited by 71
TREM2 regulates innate immunity in Alzheimer’s disease
Li, J.-T., & Zhang, Y. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1148-y · Cited by 76
“According to the cell type and context, the strength [60] and duration [61] of the stimuli is different.”
BackgroundHebron, M. L., Peyton, M. A., Liu, X., Gao, X., Wang, R., Lonskaya, I., & Moussa, C. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.07.009 · Cited by 76
Tang, W., Lv, B., Yang, B., Chen, Y., Yuan, F., Ma, L., Chen, S., Zhang, S., & Xia, J. (2019) · Oncogenesis · doi:10.1038/s41389-018-0115-x · Cited by 66
Exploring the Impact of TREM2 in Tumor-Associated Macrophages
Khantakova, D., Brioschi, S., & Molgora, M. (2022) · Vaccines · doi:10.3390/vaccines10060943 · Cited by 76
Tang, Y., Kwiatkowski, D. J., & Henske, E. P. (2022) · Nature Communications · doi:10.1038/s41467-022-32673-7 · Cited by 72
Kcnn4 Is a Regulator of Macrophage Multinucleation in Bone Homeostasis and Inflammatory Disease
Kang, H., Kerloc’h, A., Rotival, M., Xu, X., Zhang, Q., D’Souza, Z., Kim, M. S., Scholz, J. A. C., Ko, J., Srivastava, P. K., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.032 · Cited by 72
Discovery and Development of Small Molecule SHIP Phosphatase Modulators
Viernes, D. R., Choi, L. B., Kerr, W. G., & Chisholm, J. D. (2014) · Medicinal Research Reviews · doi:10.1002/med.21305 · Cited by 55
Self-citationTREM‐2 Promotes Macrophage‐Mediated Eradication of Pseudomonas aeruginosa via a PI3K/Akt Pathway
Zhu, M., Li, D., Wu, Y., Huang, X., & Wu, M. (2014) · Scandinavian Journal of Immunology · doi:10.1111/sji.12148 · Cited by 65
Holmannová, D., Koláčková, M., Kondělková, K., Kuneš, P., Krejsek, J., & Andrýs, C. (2012) · Acta Medica (Hradec Kralove, Czech Republic) · doi:10.14712/18059694.2015.68 · Cited by 67
Microglia, Trem2, and Neurodegeneration
Shi, Q., Gutierrez, R. A., & Bhat, M. A. (2025) · The Neuroscientist · doi:10.1177/10738584241254118 · Cited by 69
Wang, Y., Cao, C., Zhu, Y., Fan, H., Liu, Q., Liu, Y., Chen, K., Wu, Y., Liang, S., Li, M., et al. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-05193-x · Cited by 69
Peng, Q., Long, C. L., Malhotra, S., & Humphrey, M. B. (2013) · Science Signaling · doi:10.1126/scisignal.2003801 · Cited by 62
Self-citationSun, M., Zhu, M., Chen, K., Nie, X., Deng, Q., Hazlett, L. D., Wu, Y., Li, M., Wu, M., & Huang, X. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-10938 · Cited by 66
Belsare, K. D., Wu, H., Mondal, D., Bond, A., Castillo, E., Jin, J., Jo, H., Roush, A. E., Pilla, K. B., Sali, A., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2114486119 · Cited by 68
The triggering receptor expressed on myeloid cells (TREM) in inflammatory bowel disease pathogenesis
Genua, M., Rutella, S., Correale, C., & Danese, S. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0293-z · Cited by 68
Zhang, G., Lü, J., Zheng, J., Mei, S., Li, H., Zhang, X., Ping, A., Gao, S., Fang, Y., & Yu, J. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.375343 · Cited by 66
Turning enemies into allies—reprogramming tumor-associated macrophages for cancer therapy
Molgora, M., & Colonna, M. (2021) · Med · doi:10.1016/j.medj.2021.05.001 · Cited by 65
Hamilton, M. J., Ho, V. W., Kuroda, E., Rüschmann, J., Antignano, F., Lam, V., & Krystal, G. (2010) · Experimental Hematology · doi:10.1016/j.exphem.2010.11.002 · Cited by 66
Molecular and Cellular Mechanisms of Mammalian Cell Fusion
Zhou, X., & Platt, J. L. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-0763-4_4 · Cited by 65
Magno, L., Bunney, T. D., Mead, E., Svensson, F., & Bictash, M. N. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00436-5 · Cited by 64
Microglia gone awry: linking immunometabolism to neurodegeneration
Afridi, R., Lee, W.-H., & Suk, K. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00246 · Cited by 64
Down-regulation of microRNA-155 attenuates retinal neovascularization via the PI3K/Akt pathway.
Zhuang, Z., Xiaoqin, Hu, H., Shi-yuan, T., Lu, Z., Zhang, T., & Bai, Y.-L. (2015) · PubMed Central · Cited by 64
Lue, L.-F., Schmitz, C., & Walker, D. G. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.09.050 · Cited by 63
“It is signaled through TREM2/DAP12-mediated downstream phosphorylation of phosphoinositide 3 kinase (PI3K) and subsequent generation of phosphatidylinositol (3,4,5)-trisphosphate (PIP3) and the Linker for Activating T Cells (LAT)-mediated pathway.”
Influential(ADNI), A. D. N. I., Kleineidam, L., Chouraki, V., Próchnicki, T., van der Lee, S. J., Madrid-Márquez, L., Wagner-Thelen, H., Karaca, I., Weinhold, L., Wolfsgruber, S., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02138-6 · Cited by 62
“While research identified APOE as a ligand for TREM2 [67, 84] and PLCG2 as an important element of the TREM2 downstream signaling cascade [54], a link between PLCG2 and APOE is currently missing.”
BackgroundTriggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma
Peshoff, M., Gupta, P., Oberai, S., Trivedi, R., Katayama, H. G., Chakrapani, P., Dang, M., Migliozzi, S., Gumin, J., Kadri, D. B., et al. (2024) · Neuro-Oncology · doi:10.1093/neuonc/noad257 · Cited by 62
INPP5D deficiency attenuates amyloid pathology in a mouse model of Alzheimer's disease
Lin, P. B., Tsai, A. P., Soni, D., Lee‐Gosselin, A., Moutinho, M., Puntambekar, S. S., Landreth, G. E., Lamb, B. T., & Oblak, A. L. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12849 · Cited by 61
Pan-SHIP1/2 inhibitors promote microglia effector functions essential for CNS homeostasis
Pedicone, C., Fernandes, S., Dungan, O. M., Dormann, S. M., Viernes, D. R., Adhikari, A. A., Choi, L. B., De Jong, E. P., Chisholm, J. D., & Kerr, W. G. (2020) · Journal of Cell Science · doi:10.1242/jcs.238030 · Cited by 61
Self-citationOsteoimmunology: the expanding role of immunoreceptors in osteoclasts and bone remodeling
Long, C. L., & Humphrey, M. B. (2012) · BoneKEy Reports · doi:10.1038/bonekey.2012.59 · Cited by 61
Self-citationTargeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapy
Sanctis, F. D., Adamo, A., Canè, S., & Ugel, S. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00965-1 · Cited by 58
Takegahara, N., Kim, H., Mizuno, H., Sakaue-Sawano, A., Miyawaki, A., Tomura, M., Kanagawa, O., Ishii, M., & Choi, Y. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.677427 · Cited by 57
Yao, Y., Li, H., Chen, J., Xu, W., Yang, G., Bao, Z., Xia, D., Lu, G., Hu, S., & Zhou, J. (2016) · Oncotarget · doi:10.18632/oncotarget.8813 · Cited by 49
Cell Fusion in Health and Disease
Dittmar, T., & Zänker, K. S. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-0763-4 · Cited by 57
Carbajosa, G., Malki, K., Lawless, N., Wang, H., Ryder, J. W., Wozniak, E., Wood, K., Mein, C. A., Dobson, R. J. B., Collier, D. A., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.04.019 · Cited by 49
Hu, M., Lin, Y., Men, X., Wang, S., Sun, X., Zhu, Q., Lu, D., Liu, S., Zhang, B., Cai, W., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02144-9 · Cited by 55
Blanco-Menéndez, N., del Fresno, C., Fernandes, S., Calvo, E., Conde-Garrosa, R., Kerr, W. G., & Sancho, D. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402874 · Cited by 52
Self-citationPocock, J., Vasilopoulou, F., Svensson, E., & Cosker, K. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110020 · Cited by 54
Cosker, K., Mallach, A., Limaye, J., Piers, T. M., Staddon, J., Neame, S. J., Hardy, J., & Pocock, J. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-91207-1 · Cited by 54
Jiang, J., Ding, Y., Wu, M., Lyu, X., Wang, H., Chen, Y., Wang, H., & Teng, L. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01765 · Cited by 52
“Studies have shown that a dysregulation of this signaling pathway leads to a wide range of pathophysiological changes and diseases, such as aging (59), bone cysts (61) and Alzheimer’s disease (62).”
BackgroundThe therapeutic potential of TREM2 in cancer
Wolf, E. M., Fingleton, B., & Hasty, A. H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.984193 · Cited by 52
Zhao, P., Xu, Y., Fan, X., Li, L., Li, X., Arase, H., Tong, Q., Zhang, N., & An, Z. (2022) · mAbs · doi:10.1080/19420862.2022.2107971 · Cited by 51
Beck, T. N., Nicolas, E., Kopp, M. C., & Golemis, E. A. (2014) · Oncoscience · doi:10.18632/oncoscience.64 · Cited by 50
“TREM2 is a membrane bound protein that is activated by as of yet unidentified ligands to trigger SFK dependent phosphorylation of DAP12, leading to SYK activation, which then engages in a reciprocal activation interplay with PTK2B [51-56].”
BackgroundBao, M., Hanabuchi, S., Facchinetti, V., Du, Q., Bover, L., Plumas, J., Chaperot, L., Cao, W., Qin, J., Sun, S.-C., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200887 · Cited by 49
Mechanistic insights into the deleterious roles of Nasu-Hakola disease associated TREM2 variants
Dash, R., Choi, H. J., & Moon, I. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-60561-x · Cited by 49
DOK3 Negatively Regulates LPS Responses and Endotoxin Tolerance
Peng, Q., O’Loughlin, J. L., & Humphrey, M. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039967 · Cited by 49
Self-citationRoles of TREM2 in the Pathological Mechanism and the Therapeutic Strategies of Alzheimer's Disease
Lin, M., Yu, J., Zhang, W., Lao, F., & Huang, H. (2024) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2024.164 · Cited by 50
Neuroinflammation in Alzheimer's disease and beneficial action of luteolin
Delgado, A., Cholevas, C., & Theoharides, T. C. (2021) · BioFactors · doi:10.1002/biof.1714 · Cited by 48
Singh, H., Rai, V., Nooti, S. K., & Agrawal, D. K. (2021) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2021.1883587 · Cited by 47
Formation and biological activities of foreign body giant cells in response to biomaterials
Cai, F., Jiang, B., & He, F. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.08.034 · Cited by 47
Immune dysfunction in Alzheimer disease
Butovsky, O., Rosenzweig, N., Kleemann, K. L., Jorfi, M., Kuchroo, V. K., Tanzi, R. E., & Weiner, H. L. (2025) · Nature reviews. Neuroscience · doi:10.1038/s41583-025-00997-0 · Cited by 48
Singh, A. K., Mishra, G., Maurya, A., Awasthi, R., Kumari, K., Thakur, A., Rai, A., Rai, G. K., Sharma, B., Kulkarni, G. T., et al. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190903102822 · Cited by 48
Role of SHIP1 in cancer and mucosal inflammation
Fernandes, S., Iyer, S., & Kerr, W. G. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12038 · Cited by 42
Self-citationSamuels, J. D., Moore, K. A., Ennerfelt, H. E., Johnson, A. M., Walsh, A. E., Price, R. J., & Lukens, J. R. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13089 · Cited by 46
Synapses, Microglia, and Lipids in Alzheimer’s Disease
Paasila, P. J., Aramideh, J. A., Sutherland, G. T., & Graeber, M. B. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.778822 · Cited by 47
Zhang, N., Ji, Q., Chen, Y., Wen, X., & Shan, F. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06579-9 · Cited by 45
Effects of Isoform-selective Phosphatidylinositol 3-Kinase Inhibitors on Osteoclasts
Shugg, R. P. P., Thomson, A., Tanabe, N., Kashishian, A., Steiner, B. H., Puri, K. D., Pereverzev, A., Lannutti, B. J., Jirik, F. R., Dixon, S. J., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.507525 · Cited by 45
Genetic risk factors for Alzheimer disease: emerging roles of microglia in disease pathomechanisms
Takatori, S., Wang, W., Iguchi, A., & Tomita, T. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-05542-4_5 · Cited by 44
Xu, H., Mu, S., & Qin, W. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.08.130 · Cited by 44
TREM2+ macrophages: a key role in disease development
Wang, X., Wang, Y., Yang, L. X., Zhang, Y., & Yang, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1550893 · Cited by 44
Diabetic phenotype in mouse and humans reduces the number of microglia around β-amyloid plaques
Natunen, T., Martiskainen, H., Marttinen, M., Gabbouj, S., Koivisto, H., Kemppainen, S., Kaipainen, S., Takalo, M., Svobodová, H., Leppänen, L., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00415-2 · Cited by 35
INPP5D modulates TREM2 loss-of-function phenotypes in a β-amyloidosis mouse model
Iguchi, A., Takatori, S., Kimura, S., Muneto, H., Wang, K., Etani, H., Ito, G., Sato, H., Hori, Y., Sasaki, J., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106375 · Cited by 42
Targeting SHIP1 and SHIP2 in Cancer
Pedicone, C., Meyer, S. T., Chisholm, J. D., & Kerr, W. G. (2021) · Cancers · doi:10.3390/cancers13040890 · Cited by 42
Self-citationRoles of TREM2 in Alzheimer’s disease
Qi, X., Zhu, K., Ke, W., Wang, J., Mao, S., & Chen, G. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00515-3 · Cited by 42
Reales‐Calderón, J. A., Sylvester, M., Strijbis, K., Jensen, O. N., Nombela, C., Molero, G., & Gil, C. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.06.026 · Cited by 42
Kim, K., Park, S.-E., Park, J.-S., & Choi, J. (2022) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000842 · Cited by 42
INPP5D mRNA Expression and Cognitive Decline in Japanese Alzheimer’s Disease Subjects
Yoshino, Y., Yamazaki, K., Ozaki, Y., Sao, T., Yoshida, T., Mori, T., Mori, Y., Ochi, S., Iga, J.-I., & Ueno, S.-I. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-161211 · Cited by 41
TREM2 acts as a receptor for IL-34 to suppress acute myeloid leukemia in mice
Xie, X., Zhang, W., Xiao, M., Wei, T., Qiu, Y., Qiu, J., Wang, H., Qiu, Z., Zhang, S., Pan, Y., et al. (2023) · Blood · doi:10.1182/blood.2022018619 · Cited by 42
Targeted genetic analysis of cerebral blood flow imaging phenotypes implicates the INPP5D gene
Yao, X., Risacher, S. L., Nho, K., Saykin, A. J., Wang, Z., & Shen, L. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.06.003 · Cited by 40
Cheng, B., Li, X., Dai, K., Duan, S., Rong, Z., Chen, Y., Lü, L., Liu, Z., Huang, X., Xu, H., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.633796 · Cited by 40
Role of Inositol Poly-Phosphatases and Their Targets in T Cell Biology
Srivastava, N., Sudan, R., & Kerr, W. G. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00288 · Cited by 40
Self-citationFeiten, A. F., Dahm, K., Schlepckow, K., van Lengerich, B., Suh, J. H., Reifschneider, A., Wefers, B., Bartos, L. M., Wind-Mark, K., de Weerd, L., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68706-8 · Cited by 39
Small molecule targeting of SHIP1 and SHIP2
Kerr, W. G., Pedicone, C., Dormann, S., Pacherille, A., & Chisholm, J. D. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190775 · Cited by 39
Self-citationIvashkiv, L. B. (2011) · Science Signaling · doi:10.1126/scisignal.2001917 · Cited by 38
Yu, H., Zhang, L., Song, B., Ren, K., Chen, X., Dai, Y., Yang, Y., Xu, Y., & Wei, Z. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06799-3 · Cited by 38
Choo, Y.-Y., Trần, P. T., Min, B.-S., Kim, O., Nguyen, H. D., Kwon, S., & Lee, J. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.09.018 · Cited by 37
Role of Microglia in Regulating Cholesterol and Tau Pathology in Alzheimer’s Disease
Nanjundaiah, S., Chidambaram, H., Chandrashekar, M., & Chinnathambi, S. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00883-6 · Cited by 36
Zheng, L., Ren, L., Kouhi, A., Khawli, L. A., Hu, P., Kaslow, H. R., & Epstein, A. L. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3417 · Cited by 36
TREM2 and Microglia Contribute to the Synaptic Plasticity: from Physiology to Pathology
Yu, C.-J., Wang, M., Ruiyang, L., Wei, T., Yang, H.-C., Yin, Y., Mi, Y., Qin, Q., & Tang, Y. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03100-1 · Cited by 36
Etxeberria, A., Shen, Y.-A. A., Vito, S., Silverman, S. M., Imperio, J., Lalehzadeh, G., Soung, A. L., Du, C., Xie, L., Choy, M. K., et al. (2024) · The Journal of Neuroscience · doi:10.1523/jneurosci.2347-23.2024 · Cited by 35
Myelin debris phagocytosis in demyelinating disease
Gao, R., Song, S., Tian, M., Wang, L., Zhang, Y., & Li, X. (2024) · Glia · doi:10.1002/glia.24602 · Cited by 35
Cai, X., Xing, J., Long, C. L., Peng, Q., & Humphrey, M. B. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3205 · Cited by 35
Self-citationMatera, A., Compagnion, A.-C., Pedicone, C., Kotah, J. M., Ivanov, A., Monsorno, K., Labouèbe, G., Leggio, L., Pereira-Iglesias, M., Beule, D., et al. (2025) · Immunity · doi:10.1016/j.immuni.2024.11.003 · Cited by 34
“8,11 Therefore, SHIP1 has multiple functions and may influence microglial intracellular signaling through both phosphatase-dependent and independent mechanisms.”
Self-citationKonishi, H., & Kiyama, H. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104878 · Cited by 35
Variant TREM2 Signaling in Alzheimer's Disease
Olufunmilayo, E. O., & Holsinger, R. M. D. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167470 · Cited by 34
Protein tyrosine phosphatases in skeletal development and diseases
Yang, H., Wang, L., Shigley, C., & Yang, W. (2022) · Bone Research · doi:10.1038/s41413-021-00181-x · Cited by 34
Role of inhibitory signaling in peripheral B cell tolerance*
Getahun, A. (2022) · Immunological Reviews · doi:10.1111/imr.13070 · Cited by 34
TREM2, microglial and ischemic stroke
Wang, H., Li, X., Wang, Q., Ma, J., Gao, X., & Wang, M. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578108 · Cited by 34
Ni, J., Xie, Z., Quan, Z., Meng, J., & Qing, H. (2023) · Glia · doi:10.1002/glia.24465 · Cited by 34
The immunoreceptor adapter protein DAP12 suppresses B lymphocyte–driven adaptive immune responses
Nakano-Yokomizo, T., Tahara‐Hanaoka, S., Nakahashi-Oda, C., Nabekura, T., Tchao, N. K., Kadosaki, M., Totsuka, N., Kurita, N., Nakamagoe, K., Tamaoka, A., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20101623 · Cited by 34
Steiner, A., Schlepckow, K., Brunner, B., Steiner, H., Haass, C., & Hagn, F. (2020) · The EMBO Journal · doi:10.15252/embj.2019104247 · Cited by 33
Adipoclast: a multinucleated fat-eating macrophage
Olona, A., Mukhopadhyay, S., Hateley, C., Martínez, F. O., Gordon, S., & Behmoaras, J. V. (2021) · BMC Biology · doi:10.1186/s12915-021-01181-3 · Cited by 33
Lineage extrinsic and intrinsic control of immunoregulatory cell numbers by SHIP
Collazo, M. M., Paraiso, K. H. T., Park, M., Hazen, A. L., & Kerr, W. G. (2012) · European Journal of Immunology · doi:10.1002/eji.201142092 · Cited by 30
Self-citationKorvatska, O., Kiianitsa, K., Ratushny, A., Matsushita, M., Beeman, N., Chien, W.-M., Satoh, J.-I., Dorschner, M. O., Keene, C. D., Bammler, T. K., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.559342 · Cited by 33
TREM2: Keeping Pace With Immune Checkpoint Inhibitors in Cancer Immunotherapy
Qiu, H., Shao, Z., Wen, X., Jiang, J., Ma, Q., Wang, Y., Huang, L., Ding, X., & Zhang, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.716710 · Cited by 32
“Moreover, TREM2-DAP10 also promotes signal transmission by recruiting PI3K and activating Akt and ERK (43, 47).”
BackgroundTREM2 aggravates sepsis by inhibiting fatty acid oxidation via the SHP1/BTK axis
Ming, S., Li, X., Xiao, Q., Qu, S., Wang, Q., Fang, Q., Liang, P., Xu, Y., Yang, J., Yang, Y., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci159400 · Cited by 31
RetractedContributions of triggering-receptor-expressed-on-myeloid-cells-2 to neurological diseases
Han, J., Wang, M., Ren, M., & Lou, H. (2017) · International Journal of Neuroscience · doi:10.1080/00207454.2016.1264072 · Cited by 30
Integrating Phosphoproteome and Transcriptome Reveals New Determinants of Macrophage Multinucleation
Rotival, M., Ko, J., Srivastava, P. K., Kerloc’h, A., Montoya, A., Mauro, C., Faull, P. A., Cutillas, P. R., Petretto, E. G., & Behmoaras, J. V. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.043836 · Cited by 30
Iyer, S., Margulies, B. S., & Kerr, W. G. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12091 · Cited by 30
Self-citation
Metadata
- Authors
- Peng, Q., Malhotra, S., Torchia, J. A., Kerr, W. G., Coggeshall, K. M., & Humphrey, M. B.
- Affiliations
- Jilin University (CN)
- University of Oklahoma Health Sciences Center (US)
- University of California, San Francisco (US)
- SUNY Upstate Medical University (US)
- Oklahoma Medical Research Foundation (US)
- United States Department of Veterans Affairs (US)
- Corresponding author
- Humphrey, Mary Beth
- Venue
- Science Signaling
- Published
- 2010-05-18
- Volume
- 3
- Issue
- 122
- Pages
- ra38-ra38
- ISSN
- 1937-9145 (ISSN-L)
- 1945-0877
- PMC
- PMC2900152
- OpenAlex
- W2121590561
- Cited by
- 413
- References
- 55
- Citations by year
- 2026: 41 · 2025: 43 · 2024: 49 · 2023: 44 · 2022: 41 · 2021: 34 · 2020: 28 · 2019: 16 · 2018: 21 · 2017: 16 · 2016: 11 · 2015: 13 · 2014: 14 · 2013: 11 · 2012: 14
- FWCI
- 5.47
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science Signaling (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL085580, R01HL085580, R01HL072523, HL72523)
- National Institute of Allergy and Infectious Diseases (U19AI062629)
- National Institute of Dental and Craniofacial Research (DE019398, R01DE019398)
- National Center for Research Resources (P20RR020143, P20 RR0201143)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Keywords
- TREM2, DAP12, DAP10, SHIP1, PI3K activation, osteoclastogenesis, macrophage fusion, ERK signaling, Vav3, calcium mobilization, actin reorganization, apoptosis, Nasu-Hakola disease, SH2 domain binding, receptor signaling regulation
- MeSH terms
- Inositol Polyphosphate 5-Phosphatases, Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases, Phosphoinositide-3 Kinase Inhibitors, Animals, Cell Division, Cell Line, Enzyme Activation, Membrane Glycoproteins, Mice, Inbred C57BL, Osteoclasts, Phosphoric Monoester Hydrolases, Phosphorylation, Receptors, Immunologic, Signal Transduction, src Homology Domains, Phosphatidylinositol 3-Kinases, Adaptor Proteins, Signal Transducing, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.